Strategies for regulation of innovative non-vaccine biologics for disease prevention in China: a SWOT analysis
With globally increasing diversification of biomedical technologies, a large number of innovative biologics, such as long-acting monoclonal antibodies, have shown good preventive effects in clinical trials. However, in accordance with current legal framework in China, such biologics cannot be regist...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Editorial Office of Chinese Journal of Public Health,
2024-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |